U.S. drug regulators on Feb. 11 announced they are pushing back a decision on whether to authorize Pfizer’s COVID-19 vaccine for children as young as 6 months old.
Despite conclusive evidence young children have virtually no risk of severe complications or death from COVID-19, Pfizer, at the urging of federal health officials, is hustling to get infants and toddlers injected with experimental COVID vaccines.
Documents obtained by NATIONAL FILE show that the University of Pennsylvania, which hosts and funds Joe Biden’s think tank called the Penn Biden Center, directly profits from the sale of Pfizer-BioNTech and Moderna Coronavirus vaccines.
Video shows man once gasping for air in a hospital bed, then working out in the gym only days after receiving corticosteroid treatment from Dr. Bartlett.
Days prior to today’s scheduled release of documents related to the Pfizer COVID vaccine, the pharmaceutical company asked a federal court to let it intervene before any information is released. The U.S. Food and Drug Administration said it agreed with the drugmaker’s request.
Medical debt is the predominant cause for about 25% of consumer bankruptcies, with medical debt often triggered by "sudden adverse events — such as vaccine-induced myocarditis.
A group of world-renowned doctors and medical experts who joined Sen. Ron Johnson (R-Wis.) for a panel discussion on COVID blasted the federal government’s response to the global pandemic, calling many of the policies “obscene, absurd, illogical and nonscientific.”
A lawsuit against Bill Gates, the Indian government and others, citing extensive case law, is attracting renewed scrutiny of Gates and his long-term, controversial involvement in India’s vaccine program.
Despite the FDA’s claim that it is committed to transparency, especially for COVID-19 emergency use authorizations (EUAs), the agency first requested 55 years to release the data supporting the approval of Comirnaty after a Freedom of Information Act (FOIA) request was led, and then asked for an extra 20 years to fully comply.
One of India’s top health officials made major news last week with an announcement about safety concerns regarding an experimental treatment for COVID-19.
